January 26-28, 2021
Monitoring the safety of medicines has always been a top priority for life science companies, regulators, healthcare providers and patients. The COVID-19 pandemic has created numerous challenges across the healthcare landscape, from patient access to care and the conduct of clinical trials, to data collection for clinical safety and post-market pharmacovigilance. DIA’s Pharmacovigilance and Risk Management Strategies Conference provides an opportunity to connect with global industry experts to discuss such challenges and provide solutions for strong strategic planning and practical decision-making in setting up robust pharmacovigilance programs.
Join us at the virtual coffee corner session on January 26, 2021, 11.00am -11.30 am EST led by Dr. Jay Dave, Risk Management Lead and Dr. Vineet Kacker, Co-Founder, Managing Director & Global Technical Head along with other APCER subject matter experts. Our speakers will be discussing on the topic ‘Transitioning to Digital Risk Minimization – The journey to our new normal’ which will provide insights on:
- Current regulatory challenges
- How COVID has catalyzed digital adoption from a risk management perspective
- Implementing an effective Digital Risk Management system with real world examples
Click here to learn more